Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD

Thorax

Volumn 73, Issue 10, 2018, Pages 942-950

  Charususin, Noppawan ^a,b,c   Gosselink, Rik ^a,b   Decramer, Marc ^a   Demeyer, Heleen ^a,b   McConnell, Alison ^d   Saey, Didier ^e   Maltais, François ^e   Derom, Eric ^f   Vermeersch, Stefanie ^f   Heijdra, Yvonne F ^g   Van Helvoort, Hanneke ^g   Garms, Linda ^g   Schneeberger, Tessa ^h   Kenn, Klaus ^h,i   Gloeckl, Rainer ^h,j   Langer, Daniel ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KU Leuven   (Belgium)

^c THAMMASAT UNIVERSITY   (Thailand)

^d BOURNEMOUTH UNIVERSITY   (United Kingdom)

^e LAVAL UNIVERSITY   (Canada)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Dept of Respiratory Medicine and Exercise Therapy   (Germany)

ⁱ JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

exercise; pulmonary rehabilitation; respiratory muscles

Indexed keywords

AGED; ARTICLE; BREATHING EXERCISE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAPHRAGM PARALYSIS; DOUBLE BLIND PROCEDURE; DYSPNEA; ENDURANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INSPIRATORY MUSCLE TRAINING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL; SIX MINUTE WALK TEST; THERAPY EFFECT; BREATHING MUSCLE; CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; WALK TEST;

AGED; BREATHING EXERCISES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES; WALK TEST;

EID: 85048865332     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-211417     Document Type: Article

References (34)

1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med 2017.
2. Decramer M, Demedts M, Rochette F, et al. Maximal transrespiratory pressures in obstructive lung disease. Bull Eur Physiopathol Respir 1980;16:479-90.
3. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity, exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
4. Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clin Chest Med 1988;9:237-48.
5. G osselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
6. L aghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003;168:10-48.
7. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-e64.
8. McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015:CD003793. CD003793.
9. G osselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: What is the evidence? Eur Respir J 2011;37:416-25.
10. A mbrosino N. The case for inspiratory muscle training in COPD. Eur Respir J 2011;37:233-5.
11. McConnell AK. CrossTalk opposing view: Respiratory muscle training does improve exercise tolerance. J Physiol 2012;590:3397-8.
12. Patel MS, Hart N, Polkey MI. CrossTalk proposal: Training the respiratory muscles does not improve exercise tolerance. J Physiol 2012;590:3393-5.
13. Polkey MI, Moxham J, Green M. The case against inspiratory muscle training in COPD. Against. Eur Respir J 2011;37:236-7.
14. Spruit MA, Pitta F, Garvey C, et al. American Association of C, Pulmonary R, Assembly AT SPR and the ERSCAt. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J 2014;43:1326-37.
15. Decramer M. Response of the respiratory muscles to rehabilitation in COPD. J Appl Physiol 2009;107:971-6.
16. C harususin N, Gosselink R, Decramer M, et al. Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): A multicentre randomised controlled trial. BMJ Open 2013;3:e003101.
17. Fregni F, Imamura M, Chien HF, et al. Challenges and recommendations for placebo controls in randomized trials in physical and rehabilitation medicine: A report of the international placebo symposium working group. Am J Phys Med Rehabil 2010;89:160-72.
18. L anger D, Charususin N, Jácome C, et al. Efficacy of a Novel Method for Inspiratory Muscle Training in People With Chronic Obstructive Pulmonary Disease. Phys Ther 2015;95:1264-73.
19. T roosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14:270-4.
20. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011;37:784-90.
21. A lshurafa M, Briel M, Akl EA, et al. Inconsistent definitions for intention-to-treat in relation to missing outcome data: Systematic review of the methods literature. PLoS One 2012;7:e49163.
22. Vickers AJ, Altman DG. Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123-4.
23. Holland AE, Nici L. The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:335-6.
24. C amillo CA, Osadnik CR, van Remoortel H, et al. Effect of "add-on" interventions on exercise training in individuals with COPD: A systematic review. ERJ Open Res 2016;2:00078-2015.
25. C azzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: From lung function to biomarkers. Eur Respir J 2008;31:416-69.
26. L aviolette L, Bourbeau J, Bernard S, et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 2008;63:115-21.
27. Pepin V, Brodeur J, Lacasse Y, et al. Six-minute walking versus shuttle walking: Responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 2007;62:291-8.
28. Maltais F, Hamilton A, Trampisch M, et al. Effect of Once-Daily Tiotropium and Olodaterol, Alone and Combined With Exercise Training, on Two Measures of Walking Capacity in Patients With COPD. Chest 2016;150:853A.
29. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428-46.
30. C harususin N, Gosselink R, McConnell A, et al. Inspiratory muscle training improves breathing pattern during exercise in COPD patients. Eur Respir J 2016;47:1261-4.
31. Mahler DA, Witek TJ. The MCID of the transition dyspnea index is a total score of one unit. COPD 2005;2:99-103.
32. Banzett RB, O'Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnea Profile: An instrument for clinical and laboratory research. Eur Respir J 2015;45:1681-91.
33. C indy Ng LW, Mackney J, Jenkins S, et al. Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis 2012;9:17-26.
34. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.